| 1852 | A | 061658 | 002 | TETRACYCLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | BRISTACYCLINE | BRISTOL | 500MG | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | 27786400bf9879363b07df2aadff375f7c809f85d01decf126c946aeeecef497 |
| 1853 | A | 061888 | 002 | TETRACYCLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | BRISTACYCLINE | BRISTOL | 500MG | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | 4a6929d23a86352b9cc93901e4f74a8daa8a8465bf64bafa16b6ebf6b93e925e |
| 1854 | A | 075100 | 001 | BROMOCRIPTINE MESYLATE | CAPSULE;ORAL | CAPSULE | ORAL | BROMOCRIPTINE MESYLATE | LEK PHARM | EQ 5MG BASE | | [] | 1998-12-10 | Dec 10, 1998 | No | No | No | DISCN | LEK PHARMACEUTICAL AND CHEMICAL CO DD | b9e46818b5f439209f8bd9fee0ff3f159d2f315cd624f8816be003d929d24653 |
| 1855 | A | 077226 | 001 | BROMOCRIPTINE MESYLATE | CAPSULE;ORAL | CAPSULE | ORAL | BROMOCRIPTINE MESYLATE | MYLAN | EQ 5MG BASE | AB | ["AB"] | 2005-04-04 | Apr 4, 2005 | No | No | Yes | RX | MYLAN PHARMACEUTICALS INC | 16d1039f2b0837d514642643d5e371d4d76b6e47b22889e1187953db4ebb0d80 |
| 1856 | A | 078899 | 001 | BROMOCRIPTINE MESYLATE | CAPSULE;ORAL | CAPSULE | ORAL | BROMOCRIPTINE MESYLATE | ZYDUS PHARMS USA INC | EQ 5MG BASE | AB | ["AB"] | 2008-07-30 | Jul 30, 2008 | No | No | No | RX | ZYDUS PHARMACEUTICALS USA INC | 7c80f34726020a78b39be11cc12e80a71f6dde65404a0623d535efa417616555 |
| 1857 | A | 085264 | 001 | THEOPHYLLINE | CAPSULE;ORAL | CAPSULE | ORAL | BRONKODYL | SANOFI AVENTIS US | 100MG | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | SANOFI AVENTIS US LLC | f7d0c9dc8bbe64dc7f5320bcadd50403b0d33ae01d4b6738ef6e5740ea26e51d |
| 1858 | A | 085264 | 002 | THEOPHYLLINE | CAPSULE;ORAL | CAPSULE | ORAL | BRONKODYL | SANOFI AVENTIS US | 200MG | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | SANOFI AVENTIS US LLC | 7a979484e7ffe589bfa44b48c8fe6a4fa818a13c308f6171cdb5497a47d101fe |
| 1859 | N | 213217 | 001 | ZANUBRUTINIB | CAPSULE;ORAL | CAPSULE | ORAL | BRUKINSA | BEIGENE | 80MG | | [] | 2019-11-14 | Nov 14, 2019 | No | Yes | Yes | RX | BEIGENE USA INC | 2df8c48854e07a7639b00723a3ed05b1bc921cd36b7ddeaeaff5200a51e81695 |
| 1860 | A | 088991 | 001 | ACETAMINOPHEN; BUTALBITAL | CAPSULE;ORAL | CAPSULE | ORAL | BUCET | MALLINCKRODT | 650MG;50MG | | [] | 1985-06-28 | Jun 28, 1985 | No | No | No | DISCN | MALLINCKRODT CHEMICAL INC | 3b79549595bde4b78106c82823d33e7a70ebf92dd0b24c0f0608c598db9f8a08 |
| 1861 | A | 206724 | 001 | BUDESONIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUDESONIDE | ALVOGEN | 3MG | | [] | 2016-11-23 | Nov 23, 2016 | No | No | No | DISCN | ALVOGEN INC | 64d55f3fe054fbc89dccc136e8a61d07a5baa22c793b6c8943832d52f3dcd2a8 |
| 1862 | A | 206200 | 001 | BUDESONIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUDESONIDE | AMNEAL PHARMS | 3MG | AB | ["AB"] | 2017-07-31 | Jul 31, 2017 | No | No | No | RX | AMNEAL PHARMACEUTICALS OF NEW YORK LLC | 5345a68cb90b8f5095c31b38ef9b352d59c015c3e9d415f4828c96afc7b72fa3 |
| 1863 | A | 090379 | 001 | BUDESONIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUDESONIDE | BARR LABS DIV TEVA | 3MG | | [] | 2014-04-02 | Apr 2, 2014 | No | No | No | DISCN | BARR LABORATORIES INC SUB TEVA PHARMACEUTICALS USA | 0d217273cc43f6242d80625fd654be5bf749ccd69619c14028b21006aa11525a |
| 1864 | A | 206623 | 001 | BUDESONIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUDESONIDE | MAYNE PHARMA | 3MG | AB | ["AB"] | 2016-04-08 | Apr 8, 2016 | No | No | No | RX | MAYNE PHARMA LLC | 25385ce9a9adf5c14a271f41245308791ea623378ce11dc4c4434bfb62a00b64 |
| 1865 | A | 090410 | 001 | BUDESONIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUDESONIDE | MYLAN | 3MG | AB | ["AB"] | 2011-05-16 | May 16, 2011 | No | No | No | RX | MYLAN PHARMACEUTICALS INC | 8836f1944923d950d7590a5d793417297595be1ef93194f44e3f8a81e614ea7c |
| 1866 | A | 207367 | 001 | BUDESONIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUDESONIDE | RISING | 3MG | AB | ["AB"] | 2017-04-07 | Apr 7, 2017 | No | No | No | RX | RISING PHARMA HOLDINGS INC | 8327600c5337d0d33b233d4394aee1bfc6ea58c7af982ceb179e0190377d604b |
| 1867 | A | 209041 | 001 | BUDESONIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUDESONIDE | SCIECURE PHARMA INC | 3MG | AB | ["AB"] | 2017-09-28 | Sep 28, 2017 | No | No | No | RX | SCIECURE PHARMA INC | 53a10bb4146e2996341505a48d1f07da75a5d24ae83ed733ca9c5b0f8c498f29 |
| 1868 | A | 206134 | 001 | BUDESONIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUDESONIDE | ZYDUS PHARMS | 3MG | AB | ["AB"] | 2017-05-04 | May 4, 2017 | No | No | No | RX | ZYDUS PHARMACEUTICALS USA INC | f35d8746dd26f73824248ae766195b95da6c7529db3b594647140302eb0203dd |
| 1869 | N | 021190 | 001 | BUSPIRONE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUSPAR | BRISTOL MYERS SQUIBB | 5MG | | [] | 2000-12-20 | Dec 20, 2000 | No | No | No | DISCN | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE | d7a8d62429fee4788e839ab9b017d1abb74de70702bd26a319faa5623796264d |
| 1870 | N | 021190 | 002 | BUSPIRONE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUSPAR | BRISTOL MYERS SQUIBB | 7.5MG | | [] | 2000-12-20 | Dec 20, 2000 | No | No | No | DISCN | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE | 529b4de89e64e3dcb520d3440f6c339ed4653beea803502fd0a9f98e454c4cac |
| 1871 | N | 021190 | 003 | BUSPIRONE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUSPAR | BRISTOL MYERS SQUIBB | 10MG | | [] | 2000-12-20 | Dec 20, 2000 | No | No | No | DISCN | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE | f7e1e77372cb7d4f53c026e9840315da9c0df2698d008221c4697b48e0fc4168 |
| 1872 | N | 021190 | 004 | BUSPIRONE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | BUSPAR | BRISTOL MYERS SQUIBB | 15MG | | [] | 2000-12-20 | Dec 20, 2000 | No | No | No | DISCN | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE | 6ea9264c9b58a9f8bb0a724ca05521bc031ef21b0bf93480ebcb9e00f57df803 |
| 1873 | A | 213115 | 001 | ACETAMINOPHEN; BUTALBITAL | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL AND ACETAMINOPHEN | GRANULES PHARMS | 300MG;50MG | AA | ["AA"] | 2019-11-22 | Nov 22, 2019 | No | No | No | RX | GRANULES PHARMACEUTICALS INC | 75cb21f5e0bc44abf00aecc32669456c8a1b55f7dc38a8e658fd715598b8020b |
| 1874 | A | 207313 | 001 | ACETAMINOPHEN; BUTALBITAL | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL AND ACETAMINOPHEN | MAYNE PHARMA INC | 300MG;50MG | AA | ["AA"] | 2017-12-27 | Dec 27, 2017 | No | No | Yes | RX | MAYNE PHARMA INC | af34d0940fc342d13fff9e8613d8ae4af999e3b06c473f9585ac5f15d2c0306f |
| 1875 | A | 204733 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | AUROLIFE PHARMA LLC | 325MG;50MG;40MG | AA | ["AA"] | 2018-09-26 | Sep 26, 2018 | No | No | No | RX | AUROLIFE PHARMA LLC | a3ab991eeb89e6b046484a81d9336d2e03811f079f021c12cd193b53beded429 |
| 1876 | A | 088825 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | GILBERT LABS | 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1984-12-05 | Dec 5, 1984 | No | No | No | DISCN | GILBERT LABORATORIES | c8da09074b8e4d7fad99c6d6522f84d29c78926c56bd0bbabad83705769d1e92 |
| 1877 | A | 088743 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | GRAHAM DM | 325MG;50MG;40MG | | [] | 1985-07-18 | Jul 18, 1985 | No | No | No | DISCN | DM GRAHAM LABORATORIES INC | 579a74755783337b3d0b1e8d28dc64edc925727bc9f3ff528c681c99fc0a5444 |
| 1878 | A | 088765 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | GRAHAM DM | 325MG;50MG;40MG | | [] | 1985-03-27 | Mar 27, 1985 | No | No | No | DISCN | DM GRAHAM LABORATORIES INC | 63c6664c4343958bf3a99266f9fb84e8839fdd98558b51106cefad033f24b3c8 |
| 1879 | A | 089067 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | GRAHAM DM | 325MG;50MG;40MG | | [] | 1985-04-19 | Apr 19, 1985 | No | No | No | DISCN | DM GRAHAM LABORATORIES INC | 7813ff48e48c4471112e43f7d5f4e59cbe7588ce7a6908d07421daf1fe33bb03 |
| 1880 | A | 213321 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | GRANULES PHARMS | 300MG;50MG;40MG | AA | ["AA"] | 2020-04-08 | Apr 8, 2020 | No | No | No | RX | GRANULES PHARMACEUTICALS INC | 00d00f4980742be5c5463fdd491dfbe410afd58448f18e565991925cd2123b04 |
| 1881 | A | 040261 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | HIKMA | 500MG;50MG;40MG | | [] | 1998-10-28 | Oct 28, 1998 | No | No | No | DISCN | HIKMA PHARMACEUTICALS LLC | 7664c459f23b75adba4edfcae4955e2e2127d1a51ae0f8bb7dcc7394d5e2b251 |
| 1882 | A | 212082 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | LANNETT CO INC | 300MG;50MG;40MG | AA | ["AA"] | 2019-12-17 | Dec 17, 2019 | No | No | No | RX | LANNETT CO INC | e6a4692fd65f45d702f7f41dacf2a6a6ee9c71be28852830ff6c9a226df9d4b9 |
| 1883 | A | 212083 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | LANNETT CO INC | 325MG;50MG;40MG | AA | ["AA"] | 2019-12-17 | Dec 17, 2019 | No | No | No | RX | LANNETT CO INC | ba5584386a0987879c73956194793c316b841e224c62e875dd015e48bdad0227 |
| 1884 | A | 040885 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | LGM PHARMA | 300MG;50MG;40MG | AA | ["AA"] | 2009-11-16 | Nov 16, 2009 | No | No | Yes | RX | LGM PHARMA SOLUTIONS LLC | 6ab443ab8e42efb19a7eb85fa73cc30879f815934c2f174959ad09fc3333b6e9 |
| 1885 | A | 088758 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | MALLINCKRODT | 325MG;50MG;40MG | | [] | 1985-03-27 | Mar 27, 1985 | No | No | No | DISCN | MALLINCKRODT CHEMICAL INC | 6eb39f5f727c04d5fbad4426cad1add6c175c38da7f2249cc62a15bc56a4a32c |
| 1886 | A | 210817 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | MAYNE PHARMA INC | 300MG;50MG;40MG | AA | ["AA"] | 2019-12-17 | Dec 17, 2019 | No | No | No | RX | MAYNE PHARMA INC | 374fd3685728493ced3593b81da9437b184cbb49d1fa05ea1d9270ef2f39d122 |
| 1887 | A | 089007 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | MAYNE PHARMA INC | 325MG;50MG;40MG | AA | ["AA"] | 1986-03-17 | Mar 17, 1986 | No | No | Yes | RX | MAYNE PHARMA INC | 2e52d8c4942c14028ff52526d4a0f14616deb656f3b11efefe639e6db3097eef |
| 1888 | A | 207118 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | NUVO PHARMS INC | 300MG;50MG;40MG | AA | ["AA"] | 2016-10-28 | Oct 28, 2016 | No | No | No | RX | NUVO PHAMACEUTICALS INC | cf2fbd46f639350e1a17b0c0e1ed11a688fe88569f70ac38e36ae9a9080a9641 |
| 1889 | A | 213046 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | TARO PHARM INDS LTD | 300MG;50MG;40MG | AA | ["AA"] | 2020-07-01 | Jul 1, 2020 | No | No | No | RX | TARO PHARMACEUTICAL INDUSTRIES LTD | b130d49ff367ab74d157ccd4400969510b5af6b317f8f30e3ea02dd2821de227 |
| 1890 | A | 206615 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | XSPIRE PHARMA | 300MG;50MG;40MG | AA | ["AA"] | 2017-08-04 | Aug 4, 2017 | No | No | No | RX | XSPIRE PHARMA | 80ee6099986d6babcaff36142300f806551711f5fa75601510daaa9db3f55e68 |
| 1891 | A | 076528 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | ABLE | 325MG;50MG;40MG;30MG | | [] | 2003-08-21 | Aug 21, 2003 | No | No | No | DISCN | ABLE LABORATORIES INC | 8ba9e6529f41eb98183c82c4e60d65be932f877202f125bd1b669d645fb43a17 |
| 1892 | A | 075618 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | HIKMA INTL PHARMS | 325MG;50MG;40MG;30MG | | [] | 2001-03-23 | Mar 23, 2001 | No | No | No | DISCN | HIKMA INTERNATIONAL PHARMACEUTICALS LLC | 93a2819848d1d93154672998df2d12b23db988ec61e6d2b76dfea924073d207e |
| 1893 | A | 076560 | 002 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | LGM PHARMA | 300MG;50MG;40MG;30MG | | [] | 2012-07-19 | Jul 19, 2012 | No | No | No | RX | LGM PHARMA SOLUTIONS LLC | e8834b8ef191354e14af9ecbb9279f8a41caabca30bf0b8e522c37a16e94ee72 |
| 1894 | A | 076560 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | LGM PHARMA | 325MG;50MG;40MG;30MG | AB | ["AB"] | 2004-06-10 | Jun 10, 2004 | No | No | No | RX | LGM PHARMA SOLUTIONS LLC | b58aa52a1e8b12a670c24e8b93c122f27e5e305222f7f042e8330c5496a7b4a3 |
| 1895 | A | 075929 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | NOSTRUM LABS INC | 325MG;50MG;40MG;30MG | AB | ["AB"] | 2002-04-22 | Apr 22, 2002 | No | No | No | RX | NOSTRUM LABORATORIES INC | 593111751b1c2b8ef7d00f95174c187b2dd4e0d7d1c69323c521d2a8c6ca8420 |
| 1896 | A | 204649 | 001 | ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | STRIDES PHARMA | 325MG;50MG;40MG;30MG | AB | ["AB"] | 2020-07-08 | Jul 8, 2020 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | 1a871f32f532d8bff60e0eb66bb75fab7b90f7a4767a6fecf6c812d67c781e49 |
| 1897 | A | 078149 | 001 | ASPIRIN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ASPIRIN AND CAFFEINE | NOSTRUM LABS INC | 325MG;50MG;40MG | | [] | 2007-06-13 | Jun 13, 2007 | No | No | No | DISCN | NOSTRUM LABORATORIES INC | d9f89a2ef1ada05c20a391e68bd55c1f8c2bace97c8df97f8e6e14ef857ea0be |
| 1898 | A | 086231 | 002 | ASPIRIN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ASPIRIN AND CAFFEINE | WATSON LABS | 325MG;50MG;40MG | | [] | 1985-02-12 | Feb 12, 1985 | No | No | No | DISCN | WATSON LABORATORIES INC | d3c56ced7de22c498323f79e379fb727901754754372af68efaddab6c13ae91d |
| 1899 | A | 075231 | 001 | ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | LGM PHARMA | 325MG;50MG;40MG;30MG | AB | ["AB"] | 2001-11-30 | Nov 30, 2001 | No | No | No | RX | LGM PHARMA SOLUTIONS LLC | e0c37941da9677df73379e6e81facf0c1293a33314f09a593646550d58480c3c |
| 1900 | A | 203335 | 001 | ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | MAYNE PHARMA INC | 325MG;50MG;40MG;30MG | AB | ["AB"] | 2015-10-30 | Oct 30, 2015 | No | No | No | RX | MAYNE PHARMA INC | 1ec9541b09ad82db97dd5a62d097d43627ae5c387d3e84c4b636f6deeccb9727 |
| 1901 | A | 074951 | 001 | ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | STEVENS J | 325MG;50MG;40MG;30MG | AB | ["AB"] | 1998-08-31 | Aug 31, 1998 | No | No | No | RX | JEROME STEVENS PHARMACEUTICALS INC | 191909f2e9ae1afd8c0d28892987f225c71e03aed0baecafaf8b98372fe22ee0 |